You are here

Article Text

Article menu
Download PDFPDF
Letter
Mooren’s ulcer resolved with campath-1H
  1. J van der Hoek,
  2. A Azuara-Blanco,
  3. K Greiner,
  4. J V Forrester
  1. Department of Ophthalmology, Aberdeen Royal Infirmary, Aberdeen, UK
  1. Correspondence to: Augusto Azuara Blanco, MD PhD, Ophthalmology Department, Aberdeen Royal Infirmary, The Eye Clinic, Foresterhill, Aberdeen AB25 2ZN, UK; aazblanco{at}aol.com

https://doi.org/10.1136/bjo.87.7.924

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Mooren’s ulcer is a rare idiopathic peripheral ulcerative keratitis. The diagnosis is usually based on characteristic clinical features and absence of other causes of peripheral keratitis. The clinical course can be unremitting, particularly in bilateral disease, occasionally leading to total loss of stroma.1,2

    An autoimmune process is recognised as being central to the pathogenesis.

    Calgranulin-C (CaGC), produced by granulocytes and also expressed by keratocytes, appears to be the target protein for the autoimmune response that leads to Mooren’s ulcer. Previous corneal trauma2 and a higher prevalence of HLA class II subtypes have been associated with Mooren’s ulcer.

    The disease responds to immunosuppression with variable success. Surgical treatments such as conjunctival …

    View Full Text